Zoladex Long Acting 10,8 mg implant s.c. pre-filled syr. بلجيكا - الإنجليزية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoladex long acting 10,8 mg implant s.c. pre-filled syr.

astrazeneca sa-nv - goserelin acetate - eq. goserelin 10,8 mg - implant - 10,8 mg - goserelin acetate - goserelin

Zoladex Long Acting 10,8 mg Implant بلجيكا - الإنجليزية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoladex long acting 10,8 mg implant

pi pharma - goserelin acetate - implant - 10,8 mg - goserelin acetate - goserelin

Zoladex Injection تانزانيا - الإنجليزية - Tanzania Medicinces & Medical Devices Authority

zoladex injection

astrazeneca united kingdom limited, united kingdom - goserelin - injection - 36 mg/unit dose

Zoladex 3,6 mg Implant بلجيكا - الإنجليزية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoladex 3,6 mg implant

orifarm - goserelin acetate - implant - 3,6 mg - goserelin acetate - goserelin

Zoladex LA 10.8 mg Implant أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

zoladex la 10.8 mg implant

originalis b.v. - goserelin - implant - gonadotropin releasing hormone analogues; goserelin

Zoladex 10.8mg Implant أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

zoladex 10.8mg implant

astrazeneca pty ltd - goserelin -

Zoladex 3.6mg Implant أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

zoladex 3.6mg implant

astrazeneca pty ltd - goserelin -

FIRMAGON degarelix (as acetate) composite pack of 80mg powder in vial and solvent for injection in pre-filled syringe أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

firmagon degarelix (as acetate) composite pack of 80mg powder in vial and solvent for injection in pre-filled syringe

ferring pharmaceuticals pty ltd - water for injections, quantity: 4.2 ml - injection - excipient ingredients: - firmagon is a gnrh receptor blocker indicated for treatment of patients with prostate cancer in whom androgen deprivation is warranted.

FIRMAGON degarelix (as acetate) composite 120 mg powder in vial and solvent for injection in pre-filled syringe أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

firmagon degarelix (as acetate) composite 120 mg powder in vial and solvent for injection in pre-filled syringe

ferring pharmaceuticals pty ltd - water for injections, quantity: 3 ml - injection - excipient ingredients: - firmagon is a gnrh receptor blocker indicated for treatment of patients with prostate cancer in whom androgen deprivation is warranted.

SYNAREL NASAL SPRAY nafarelin (as acetate) 2mg/mL أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

synarel nasal spray nafarelin (as acetate) 2mg/ml

pfizer australia pty ltd - nafarelin, quantity: 2 mg/ml - spray, solution - excipient ingredients: benzalkonium chloride; sorbitol; glacial acetic acid; hydrochloric acid; purified water; sodium hydroxide - indications as at 31 august 1995. synarel is indicated for the hormonal management of visually proven endometriosis, including pain relief and reduction of endometriotic lesions and for use in controlled ovarian stimulation programmes prior to in-vitro fertilisation, under the supervision of an infertility specialist.